Non-functioning Entero-pancreatic Endocrine Tumor

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-02-17
Clinical Trial Update: Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour [Phase 3]
Phase 3 trial of lanreotide Autogel 120 mg in non-functioning enteropancreatic neuroendocrine tumors completed with results posted.